Workflow
募集资金置换
icon
Search documents
晶华新材: 晶华新材第四届监事会第十八次会议决议公告
Zheng Quan Zhi Xing· 2025-06-20 10:12
Group 1 - The core point of the announcement is the decision made by the supervisory board of Shanghai Jinghua Adhesive New Materials Co., Ltd. regarding the use of raised funds to replace self-raised funds previously invested in fundraising projects [1][2] - The supervisory board meeting was held on June 17, 2025, with all three supervisors present, and the meeting was conducted in accordance with relevant laws and regulations [1] - The proposal to use a total of RMB 170.1229 million to replace self-raised funds was approved unanimously by the supervisors, with 3 votes in favor and no votes against or abstaining [2] Group 2 - The company plans to replace self-raised funds with raised funds within six months of the funds being received, which complies with regulatory requirements [1]
中策橡胶: 关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
Zheng Quan Zhi Xing· 2025-06-20 09:57
Core Points - The company has received approval from the China Securities Regulatory Commission for its initial public offering (IPO) and has issued 87,448,560 shares at a price of RMB 46.50 per share, raising a total of RMB 4,066,358,040.00, with a net amount of RMB 3,932,680,740.56 after deducting issuance costs [1][2][3] - The funds raised will be allocated to various projects, including the construction of a high-performance radial tire green 5G digital factory and enhancements to existing manufacturing facilities [2][4] - The company has pre-invested RMB 240,820.05 million of its own funds into the projects and paid issuance costs prior to the arrival of the raised funds, which will be replaced by the raised funds within six months [3][5][6] Fund Allocation - The total investment amount for the projects is RMB 691,553.37 million, with specific allocations for different projects, including RMB 393,268.07 million for the construction of a tire workshop and RMB 485,000.00 million for the enhancement of the tire manufacturing industry chain [2][4] - The company has pre-paid issuance costs totaling RMB 13,367.73 million, with RMB 1,301.65 million paid from self-raised funds [5][6] Compliance and Verification - The board of directors and the supervisory board have approved the use of raised funds to replace pre-invested funds and paid issuance costs, confirming compliance with relevant regulations [6][8] - The accounting firm Tianjian has verified the pre-investment and issuance costs, affirming that the company's actions align with regulatory requirements [8][9]
兴通股份: 兴通海运股份有限公司第二届监事会第二十四次会议决议公告
Zheng Quan Zhi Xing· 2025-06-20 09:31
Meeting Overview - The second meeting of the second supervisory board of Xingtong Shipping Co., Ltd. was held on June 16, 2025, with all three supervisors present [1][2] - The meeting was convened in accordance with relevant laws, regulations, and the company's articles of association [1] Resolutions Passed - The supervisory board approved the adjustment of the proposed investment amount for fundraising projects, confirming that the decision followed necessary procedures and would not adversely affect the normal use of raised funds [1][2] - The board also approved the use of raised funds to replace self-raised funds that were previously invested in fundraising projects and to cover issuance costs, ensuring compliance with legal requirements and benefiting the company's operations [2] - A resolution was passed to change the registered capital from 280 million yuan to 325 million yuan following a specific issuance of A-shares, with the total number of shares increasing correspondingly, and the company's articles of association will be revised accordingly [2][3] Voting Results - All resolutions received unanimous approval with 3 votes in favor, and no votes against or abstentions [2][3] - The resolution regarding the change in registered capital requires submission to the shareholders' meeting for further approval [3]
古麒绒材: 第四届监事会第六次会议决议公告
Zheng Quan Zhi Xing· 2025-06-16 11:28
Group 1 - The company held its sixth meeting of the fourth Supervisory Board on June 13, 2025, with all three supervisors present, and the meeting was deemed legally valid [1] - The Supervisory Board approved the use of self-raised funds amounting to 22.3779 million yuan for pre-investment in fundraising projects and payment of part of the issuance costs totaling 4.4262 million yuan, which complies with relevant regulations [1] - The company plans to use no more than 300 million yuan of idle raised funds for cash management, which is expected to enhance fund utilization efficiency and provide better returns for shareholders [2][3] Group 2 - The company intends to temporarily supplement working capital with up to 15 million yuan of idle raised funds, which aligns with regulatory requirements and aims to improve fund efficiency [3] - The Supervisory Board also approved the use of part of the excess raised funds for permanent working capital supplementation, which is expected to lower financial costs and enhance fund utilization [4]
众捷汽车: 众捷汽车第三届监事会第七次会议决议公告
Zheng Quan Zhi Xing· 2025-06-16 11:28
第三届监事会第七次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整, 没有虚假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 证券代码:301560 证券简称:众捷汽车 公告编号:2025-017 苏州众捷汽车零部件股份有限公司 公司使用自有资金支付外汇、银行承兑汇票、人工费用、众捷精密 外购零配件款等募投项目所需资金并以募集资金等额置换,制定了相应 的操作流程,履行了必要的决策程序,有利于提高募集资金使用效率, 符合公司及股东的利益。该事项不影响公司募投项目的正常实施,不存 在变相改变募集资金用途和损害股东利益的情形。因此,同意公司使用 自有资金支付外汇、银行承兑汇票、人工费用、众捷精密外购零配件款 等募投项目款项并以募集资金等额置换。 具体内容详见公司同日披露于巨潮资讯网(www.cninfo.com.cn) 的《众捷汽车关于使用自有资金支付外汇、银行承兑汇票、人工费用等 募投项目款项并以募集资金等额置换的公告》。 表决结果:3 票同意,0 票反对,0 票弃权。 三、备查文件 《公司第三届监事会第七次会议决议》。 特此公告。 苏州众捷汽车零部件股份有限公司监事会 苏州众捷汽车零 ...
和林微纳: 第二届监事会第十四次会议决议公告
Zheng Quan Zhi Xing· 2025-06-13 10:06
Group 1 - The core viewpoint of the announcement is that the Supervisory Board of Suzhou Helin Micro-Nano Technology Co., Ltd. approved the use of self-owned funds to pay for the required funds of the fundraising project and to replace them with the raised funds [1][2] - The meeting was held on June 13, 2025, with all necessary procedures followed, and the resolution was deemed legal and effective [1] - The voting results showed unanimous support with 3 votes in favor, 0 against, and 0 abstentions [2] Group 2 - The Supervisory Board confirmed that the use of self-owned funds does not affect the normal implementation of the fundraising project and does not change the purpose of the raised funds [1]
新点软件: 新点软件第二届监事会第十五次会议决议公告
Zheng Quan Zhi Xing· 2025-06-11 09:06
Meeting Overview - The second supervisory board meeting of Guotai Xindian Software Co., Ltd. was held on June 11, 2025, with all three supervisors present [1] - The meeting was convened in accordance with the Company Law of the People's Republic of China and the company's articles of association [1] Resolutions Passed - The supervisory board approved the proposal to use self-owned funds to pay for the required funds of the fundraising project and to replace them with equivalent raised funds [1][2] - The supervisory board confirmed that the decision-making process was followed, and the implementation of this matter would not affect the normal progress of the fundraising project or harm shareholder interests [1] - The board also stated that the actions taken comply with relevant regulations, including the rules for the supervision of fundraising by listed companies and the self-regulatory guidelines of the Shanghai Stock Exchange [1]
华达科技: 华达汽车科技股份有限公司关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
Zheng Quan Zhi Xing· 2025-06-06 09:47
Core Viewpoint - The company has approved the use of raised funds to replace pre-invested self-raised funds for project investments and paid issuance expenses, ensuring compliance with regulatory requirements [1][7][8] Fundraising Overview - The company issued 10,206,185 shares at a price of RMB 29.10 per share, raising a total of RMB 296,999,983.50, with a net amount after expenses [1] - A special verification report was issued by Zhongxinghua Accounting Firm, and independent financial advisor Zhongtai Securities provided a non-objection opinion on the matter [1][8] Fund Management and Usage - The company has established a dedicated account storage system for managing raised funds, with a tripartite supervision agreement signed with Industrial and Commercial Bank of China and Zhongtai Securities [2] - The total amount allocated for cash consideration and intermediary fees is RMB 29,700,000, which accounts for 100% of the raised funds [4] Pre-Investment of Self-Raised Funds - As of May 30, 2025, the actual investment amount from self-raised funds is RMB 108,116,982.40, which includes RMB 99,913,208.80 for cash consideration and RMB 8,203,773.60 for intermediary fees [6] - The company plans to use the raised funds to replace the pre-invested self-raised funds totaling RMB 108,116,982.40 [6] Approval Process and Opinions - The board of directors and the supervisory board approved the proposal on June 6, 2025, without the need for shareholder meeting approval [6][7] - The supervisory board confirmed that the process followed necessary approval procedures and complied with relevant regulations [7] - The independent financial advisor affirmed that the proposed use of raised funds aligns with legal requirements and does not harm the interests of the company and its shareholders [8]
华达科技: 华达汽车科技股份有限公司第四届监事会第十二次会议决议公告
Zheng Quan Zhi Xing· 2025-06-06 09:43
Meeting Overview - The fourth supervisory board meeting of Huada Automotive Technology Co., Ltd. was held on June 6, 2025, in Jiangsu Province, with all three supervisors present, confirming the legality and validity of the meeting [1]. Resolutions Passed - The supervisory board approved the proposal to use raised funds to replace pre-invested project funds and paid issuance expenses, with unanimous support from all supervisors [2]. - The board also approved the use of part of the idle raised funds for cash management, emphasizing that this action complies with relevant regulations and does not harm the interests of the company or its shareholders [2][3].
爱博医疗: 688050爱博医疗 关于使用募集资金置换预先投入募投项目及已支付发行费用的自筹资金的公告
Zheng Quan Zhi Xing· 2025-05-29 12:19
Core Viewpoint - The company, Aibo Medical, has approved the use of raised funds to replace self-raised funds that were previously invested in projects and paid issuance expenses, totaling RMB 40,556,134.86 [1][2] Fundraising Overview - Aibo Medical issued 3,593,615 shares at a price of RMB 79.20 per share, raising a total of RMB 284,614,308.00 in 2024 [1] - The net amount raised after deducting related issuance expenses is less than the intended investment amount, allowing the company to use self-raised funds for initial investments [1] Investment Project Details - The total investment amount for the projects is RMB 422,430,700, with RMB 284,614,308 intended to be funded by the raised funds [1] - The company has pre-invested self-raised funds in the projects, with specific amounts detailed for each project [1] Approval Process - The board of directors and the supervisory board approved the proposal on May 29, 2025, confirming compliance with regulations regarding the replacement of funds within six months of the funds being received [1][2] Opinions from Supervisory Board and Auditors - The supervisory board agrees that the replacement of self-raised funds aligns with the company's interests and complies with relevant laws and regulations [2] - The auditing firm, Xinyong Zhonghe, confirmed that the management's report accurately reflects the situation regarding the use of self-raised funds [2]